January 2, 2010 - Volume 24 - Issue 1
pp: N1-N2,1-161
Subscribe to eTOC





Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial

Pozniak, Anton L; Morales-Ramirez, Javier; Katabira, Elly; More

AIDS . 24(1):55-65, January 2, 2010.

HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era

Degano, Bruno; Guillaume, Mathilde; Savale, Laurent; More

AIDS . 24(1):67-75, January 2, 2010.

Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial

Aslangul, Elisabeth; Assoumou, Lambert; Bittar, Randa; More

AIDS . 24(1):77-83, January 2, 2010.

Antiretroviral therapy in antenatal care to increase treatment initiation in HIV-infected pregnant women: a stepped-wedge evaluation

Killam, William P; Tambatamba, Bushimbwa C; Chintu, Namwinga; More

AIDS . 24(1):85-91, January 2, 2010.

Antiretroviral treatment changes in adults from Côte d'Ivoire: the roles of tuberculosis and pregnancy

Messou, Eugène; Anglaret, Xavier; Duvignac, Julien; More

AIDS . 24(1):93-99, January 2, 2010.

Editorial Comment

Concise Communications


CONCISE COMMUNICATION


A polymorphism in the HCP5 gene associated with HLA-B*5701 does not restrict HIV-1 in vitro

Yoon, Woohyun; Ma, Ben-Jiang; Fellay, Jacques; More

AIDS . 24(1):155-157, January 2, 2010.